Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial
Patrick G. Kehoe(University of Bristol), Bernadette McGuinness(Queen's University Belfast), Josephine Barnes(UK Dementia Research Institute), Vivek Pattan(NHS Forth Valley), Nicholas Turner(University of Bristol), Eric M. Jackson(Johns Hopkins University), Nick C. Fox(NIHR Queen Square Dementia Biomedical Research Unit), Ian B. Wilkinson(Oncotherapeutics (United States)), Matthew P. Sheridan, Tobias Langheinrich, Alan Thomas(UK Dementia Research Institute), Robert Barber(University of North Texas), Casper Nielsen(UK Dementia Research Institute), Suvarna Wagle, Rupert McShane(Oxford Health NHS Foundation Trust), Henk Mutsaerts(Amsterdam Neuroscience), Lucy Calvert, Carole H. Sudre(King's College London), Yoav Ben‐Shlomo(University of Bristol), Andrew J. Byrne, Lina Jarutyte(University of Bristol), Andrew Donaldson(University of Cape Town), Beth Howden(University of Bristol), Stephen Pearson(Devon Partnership NHS Trust), Peter Passmore(Queen's University Belfast), Tarun Kuruvilla, Madhusudan Dalvi, David M. Findlay(The University of Adelaide), Gordon W. Duncan(Western General Hospital), Ian B. Malone(UK Dementia Research Institute), Jodi Taylor(University of Bristol), Shona Clegg(UK Dementia Research Institute), Ajay Macharouthu(Crichton Royal Hospital), Peter Connelly(Queen's University Belfast), David L. Thomas(University College London), Ngoc Jade Thai(University of Bristol), Bernard Udeze, Aileen Wilson(University of Bristol), Alasdair Lawrie, Kirsty Harkness(Royal Hallamshire Hospital), Wendy Neil, Elizabeth Coulthard(North Bristol NHS Trust), Rashi Negi, Peter S Blair(University of Bristol)
Cited by 59
Related Papers
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
|Nature Genetics|2019|3.3k
Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study
|The Lancet Public Health|2020|2.3k